These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10350394)

  • 1. Concentration and bactericidal activity of fusidic acid and cloxacillin in serum and synovial fluid.
    Somekh E; Golan T; Tanay A; Poch F; Dan M
    J Antimicrob Chemother; 1999 Apr; 43(4):593-6. PubMed ID: 10350394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ex-vivo serum bactericidal activity of cefepime, ceftazidime and cloxacillin against Staphylococcus aureus.
    Dan M; Asherov J; Poch F
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):39-42. PubMed ID: 9990474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery.
    Bergeron MG; Desaulniers D; Lessard C; Lemieux M; Després JP; Métras J; Raymond G; Brochu G
    Antimicrob Agents Chemother; 1985 Jun; 27(6):928-32. PubMed ID: 4026265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusidic acid resistance in Staphylococcus aureus isolates.
    Brown EM; Thomas P
    Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
    Memikoğlu KO; Bayar B; Kurt O; Cokça F
    Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dicloxacillin and fusidic acid on the extracellular and intracellular killing of Staphylococcus aureus.
    Nielsen SL; Black FT
    J Antimicrob Chemother; 1998 Aug; 42(2):221-6. PubMed ID: 9738840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    Woodford N; Afzal-Shah M; Warner M; Livermore DM
    J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
    Rennie RP
    J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusidic acid resistance in community isolates of methicillin-susceptible Staphylococcus aureus and fusidic acid prescribing.
    Mason BW; Howard AJ; Magee JT
    J Antimicrob Chemother; 2003 Apr; 51(4):1033-6. PubMed ID: 12654748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries.
    den Heijer CD; van Bijnen EM; Paget WJ; Stobberingh EE
    Future Microbiol; 2014; 9(6):737-45. PubMed ID: 25046521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Binding of antibiotics with proteins].
    Rolinson GN
    Antibiotiki; 1971 Sep; 16(9):771-4. PubMed ID: 5003155
    [No Abstract]   [Full Text] [Related]  

  • 12. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates.
    Yu F; Liu Y; Lu C; Lv J; Qi X; Ding Y; Li D; Huang X; Hu L; Wang L
    BMC Microbiol; 2015 Oct; 15():210. PubMed ID: 26463589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative diffusion of fusidic acid, oxacillin, and pristinamycin in dermal interstitial fluid after repeated oral administration].
    Vaillant L; Le Guellec C; Jehl F; Barruet R; Sorensen H; Roiron R; Autret-Leca E; Lorette G
    Ann Dermatol Venereol; 2000 Jan; 127(1):33-9. PubMed ID: 10717560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic penetration into the infected knee. A rabbit experiment.
    Frimodt-Møller N; Riegels-Nielsen P
    Acta Orthop Scand; 1987 Jun; 58(3):256-9. PubMed ID: 3630657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus.
    O'Neill AJ; Cove JH; Chopra I
    J Antimicrob Chemother; 2001 May; 47(5):647-50. PubMed ID: 11328777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP; Grayson ML
    Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility testing and clinical effect of fusidic acid in oxacillin-resistant Staphylococcus aureus infections.
    Liu CP; Lee CM; Su SC; Li YT
    J Microbiol Immunol Infect; 1999 Sep; 32(3):194-8. PubMed ID: 10637718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcus aureus resistance to antibiotics and spread of phage types.
    Kareiviene V; Pavilonis A; Sinkute G; Liegiūte S; Gailiene G
    Medicina (Kaunas); 2006; 42(4):332-9. PubMed ID: 16687905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
    Peeters KA; Mascini EM; Blok HE; Sanders CJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
    Drugeon HB; Caillon J; Juvin ME
    J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.